Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas Regis

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The International Journal of Biological Markers|February 24, 2022
Who with suspected prostate cancer can benefit from Proclarix after multiparametric magnetic resonance imaging?Juan Morote, Miriam Campistol, Lucas Regis, et al.
European Urology Open Science|March 4, 2022
Improving the Early Detection of Clinically Significant Prostate Cancer in Men in the Challenging Prostate Imaging-Reporting and Data System 3 CategoryJuan Morote, Miriam Campistol, Marina Triquell, et al.
Molecular Diagnosis & Therapy|April 20, 2023
Relationship between Proclarix and the Aggressiveness of Prostate CancerMiriam Campistol, Marina Triquell, Lucas Regis, et al.
BJU International|August 10, 2021
The current recommendation for the management of isolated high-grade prostatic intraepithelial neoplasiaJuan Morote, Iván Schwartzmann, Anna Celma, et al.
Cancers|October 27, 2022
A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging DemandJuan Morote, Ángel Borque-Fernando, Marina Triquell, et al.
BJUI Compass|April 13, 2026
Juan Morote, Berta Miró, Lucas Regis, et al.
Cancers|April 12, 2022
Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate CancerJuan Morote, Angel Borque-Fernando, Marina Triquell, et al.
Clinical and Translational Radiation Oncology|November 29, 2023
Comparative effectiveness of new treatment modalities for localized prostate cancer through patient-reported outcome measuresVíctor Zamora, Olatz Garin, José Francisco Suárez, et al.
Urologic Oncology|November 8, 2020
Prediction of clinically significant prostate cancer after negative prostate biopsy: The current value of microscopic findingsJuan Morote, Iván Schwartzman, Angel Borque, et al.
Cancers|May 28, 2022
Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate BiopsyJuan Morote, Angel Borque-Fernando, Marina Triquell, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The International Journal of Biological Markers|February 24, 2022
Who with suspected prostate cancer can benefit from Proclarix after multiparametric magnetic resonance imaging?Juan Morote, Miriam Campistol, Lucas Regis, et al.
European Urology Open Science|March 4, 2022
Improving the Early Detection of Clinically Significant Prostate Cancer in Men in the Challenging Prostate Imaging-Reporting and Data System 3 CategoryJuan Morote, Miriam Campistol, Marina Triquell, et al.
Molecular Diagnosis & Therapy|April 20, 2023
Relationship between Proclarix and the Aggressiveness of Prostate CancerMiriam Campistol, Marina Triquell, Lucas Regis, et al.
BJU International|August 10, 2021
The current recommendation for the management of isolated high-grade prostatic intraepithelial neoplasiaJuan Morote, Iván Schwartzmann, Anna Celma, et al.
Cancers|October 27, 2022
A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging DemandJuan Morote, Ángel Borque-Fernando, Marina Triquell, et al.
BJUI Compass|April 13, 2026
Juan Morote, Berta Miró, Lucas Regis, et al.
Cancers|April 12, 2022
Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate CancerJuan Morote, Angel Borque-Fernando, Marina Triquell, et al.
Clinical and Translational Radiation Oncology|November 29, 2023
Comparative effectiveness of new treatment modalities for localized prostate cancer through patient-reported outcome measuresVíctor Zamora, Olatz Garin, José Francisco Suárez, et al.
Urologic Oncology|November 8, 2020
Prediction of clinically significant prostate cancer after negative prostate biopsy: The current value of microscopic findingsJuan Morote, Iván Schwartzman, Angel Borque, et al.
Cancers|May 28, 2022
Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate BiopsyJuan Morote, Angel Borque-Fernando, Marina Triquell, et al.
Pageof 4